These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Characterization of the relationship between serum and milk residue disposition of ceftriaxone in lactating ewes. Goudah A, Shin HC, Shim JH, Abd El-Aty AM. J Vet Pharmacol Ther; 2006 Aug; 29(4):307-12. PubMed ID: 16846468 [Abstract] [Full Text] [Related]
23. Pharmacokinetics of ceftriaxone in humans. Patel IH, Chen S, Parsonnet M, Hackman MR, Brooks MA, Konikoff J, Kaplan SA. Antimicrob Agents Chemother; 1981 Nov; 20(5):634-41. PubMed ID: 6275779 [Abstract] [Full Text] [Related]
27. [Clinical study of a new cephalosporin, ceftriaxone (Rocefin Roche) in bronchopneumonia in children]. De Marco A, Manca B. Ann Osp Maria Vittoria Torino; 1983 Nov; 26(1-6):91-6. PubMed ID: 6093666 [Abstract] [Full Text] [Related]
28. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man. Ahr HJ, Boberg M, Brendel E, Krause HP, Steinke W. Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452 [Abstract] [Full Text] [Related]
29. Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose. McNamara PJ, Stoeckel K, Ziegler WH. Eur J Clin Pharmacol; 1982 Jun; 22(1):71-5. PubMed ID: 6284519 [Abstract] [Full Text] [Related]
30. Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings. Eron LJ, Goldenberg RI, Poretz DM. Am J Surg; 1984 Oct 19; 148(4A):1-4. PubMed ID: 6091473 [Abstract] [Full Text] [Related]
35. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime. Wise R, Andrews JM. Eur J Clin Microbiol; 1983 Oct 19; 2(5):505-8. PubMed ID: 6315427 [Abstract] [Full Text] [Related]
36. Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults. Zhou HH, Chan YP, Arnold K, Sun M. Antimicrob Agents Chemother; 1985 Feb 19; 27(2):192-6. PubMed ID: 3985603 [Abstract] [Full Text] [Related]
37. Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis. Ti TY, Fortin L, Kreeft JH, East DS, Ogilvie RI, Somerville PJ. Antimicrob Agents Chemother; 1984 Jan 19; 25(1):83-7. PubMed ID: 6322683 [Abstract] [Full Text] [Related]
38. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime. Regamey C. Chemotherapy; 1985 Jan 19; 31(2):85-94. PubMed ID: 3987394 [Abstract] [Full Text] [Related]
40. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination. Ings RM, Reeves DS, White LO, Bax RP, Bywater MJ, Holt HA. J Pharmacokinet Biopharm; 1985 Apr 19; 13(2):121-42. PubMed ID: 4057054 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]